A Left‐Handed Solution to Peptide Inhibition of the P53–mdm2 Interaction
Min Liu,Marzena Pazgier,Changqing Li,Weirong Yuan,Chong Li,Wuyuan Lu
DOI: https://doi.org/10.1002/anie.201000329
2010-01-01
Angewandte Chemie
Abstract:Angewandte Chemie International EditionVolume 49, Issue 21 p. 3649-3652 Communication A Left-Handed Solution to Peptide Inhibition of the p53–MDM2 Interaction† Min Liu Dr., Min Liu Dr. Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA) The First Affiliated Hospital, Xi'an Jiaotong University School of Medicine (China) These authors contributed equally to this work.Search for more papers by this authorMarzena Pazgier Dr., Marzena Pazgier Dr. Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA) These authors contributed equally to this work.Search for more papers by this authorChangqing Li Dr., Changqing Li Dr. Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA) These authors contributed equally to this work.Search for more papers by this authorWeirong Yuan, Weirong Yuan Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA)Search for more papers by this authorChong Li, Chong Li Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA)Search for more papers by this authorWuyuan Lu Prof., Wuyuan Lu Prof. [email protected] Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA)Search for more papers by this author Min Liu Dr., Min Liu Dr. Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA) The First Affiliated Hospital, Xi'an Jiaotong University School of Medicine (China) These authors contributed equally to this work.Search for more papers by this authorMarzena Pazgier Dr., Marzena Pazgier Dr. Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA) These authors contributed equally to this work.Search for more papers by this authorChangqing Li Dr., Changqing Li Dr. Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA) These authors contributed equally to this work.Search for more papers by this authorWeirong Yuan, Weirong Yuan Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA)Search for more papers by this authorChong Li, Chong Li Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA)Search for more papers by this authorWuyuan Lu Prof., Wuyuan Lu Prof. [email protected] Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard St., Baltimore, MD 21201 (USA)Search for more papers by this author First published: 06 May 2010 https://doi.org/10.1002/anie.201000329Citations: 73 † This work was supported in part by a Research Scholar Grant CDD112858 from the American Cancer Society and the National Institutes of Health Grants AI072732 and AI061482 (to W.L.). p53=tumor suppressor protein 53; MDM2=murine double minute 2 protein. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Graphical Abstract Throwing tumors a left-hook punch: The oncoprotein MDM2 negatively regulates the activity and stability of the tumor suppressor protein p53, and is an important molecular target for anticancer therapy. Mirror-image phage display identified a high-affinity D-peptide ligand of MDM2 (see structure) that could be developed into a potent and protease-resistant p53 activator with potential antitumor activity. References 1 1aR. E. Moellering, M. Cornejo, T. N. Davis, C. Del Bianco, J. C. Aster, S. C. Blacklow, A. L. Kung, D. G. Gilliland, G. L. Verdine, J. E. Bradner, Nature 2009, 462, 182; 1bL. D. Walensky, A. L. Kung, I. Escher, T. J. Malia, S. Barbuto, R. D. Wright, G. Wagner, G. L. Verdine, S. J. Korsmeyer, Science 2004, 305, 1466. 2M. R. Arkin, J. A. Wells, Nat. Rev. Drug Discovery 2004, 3, 301. 3 3aT. N. Schumacher, L. M. Mayr, D. L. Minor, Jr., M. A. Milhollen, M. W. Burgess, P. S. Kim, Science 1996, 271, 1854; 3bD. M. Eckert, V. N. Malashkevich, L. H. Hong, P. A. Carr, P. S. Kim, Cell 1999, 99, 103. 4 4aP. E. Dawson, T. W. Muir, I. Clark-Lewis, S. B. Kent, Science 1994, 266, 776; 4bS. B. Kent, Chem. Soc. Rev. 2009, 38, 338. 5 5aC. J. Brown, S. Lain, C. S. Verma, A. R. Fersht, D. P. Lane, Nat. Rev. Cancer 2009, 9, 862; 5bS. Shangary, D. Qin, D. McEachern, M. Liu, R. S. Miller, S. Qiu, Z. Nikolovska-Coleska, K. Ding, G. Wang, J. Chen, D. Bernard, J. Zhang, Y. Lu, Q. Gu, R. B. Shah, K. J. Pienta, X. Ling, S. Kang, M. Guo, Y. Sun, D. Yang, S. Wang, Proc. Natl. Acad. Sci. USA 2008, 105, 3933; 5cL. T. Vassilev, B. T. Vu, B. Graves, D. Carvajal, F. Podlaski, Z. Filipovic, N. Kong, U. Kammlott, C. Lukacs, C. Klein, N. Fotouhi, E. A. Liu, Science 2004, 303, 844. 6 6aK. H. Vousden, D. P. Lane, Nat. Rev. Mol. Cell Biol. 2007, 8, 275; 6bF. Toledo, G. M. Wahl, Nat. Rev. Cancer 2006, 6, 909. 7 7aP. H. Kussie, S. Gorina, V. Marechal, B. Elenbaas, J. Moreau, A. J. Levine, N. P. Pavletich, Science 1996, 274, 948; 7bO. Schon, A. Friedler, M. Bycroft, S. M. Freund, A. R. Fersht, J. Mol. Biol. 2002, 323, 491. 8A. Böttger, V. Bottger, C. Garcia-Echeverria, P. Chene, H. K. Hochkeppel, W. Sampson, K. Ang, S. F. Howard, S. M. Picksley, D. P. Lane, J. Mol. Biol. 1997, 269, 744. 9M. Pazgier, M. Liu, G. Zou, W. Yuan, C. Li, J. Li, J. Monbo, D. Zella, S. G. Tarasov, W. Lu, Proc. Natl. Acad. Sci. USA 2009, 106, 4665. 10C. Li, M. Pazgier, M. Liu, W. Y. Lu, W. Lu, Angew. Chem. 2009, 121, 8868; Angew. Chem. Int. Ed. 2009, 48, 8712. 11J. C. Marine, M. A. Dyer, A. G. Jochemsen, J. Cell Sci. 2007, 120, 371. 12C. E. Schafmeister, J. Po, G. L. Verdine, J. Am. Chem. Soc. 2000, 122, 5891. 13F. Bernal, A. F. Tyler, S. J. Korsmeyer, L. D. Walensky, G. L. Verdine, J. Am. Chem. Soc. 2007, 129, 2456. 14J. K. Murray, S. H. Gellman, Biopolymers 2007, 88, 657. 15 15aR. Fasan, R. L. Dias, K. Moehle, O. Zerbe, J. W. Vrijbloed, D. Obrecht, J. A. Robinson, Angew. Chem. 2004, 116, 2161; Angew. Chem. Int. Ed. 2004, 43, 2109; 15bJ. A. Robinson, Acc. Chem. Res. 2008, 41, 1278. 16 16aJ. A. Kritzer, R. Zutshi, M. Cheah, F. A. Ran, R. Webman, T. M. Wongjirad, A. Schepartz, ChemBioChem 2006, 7, 29; 16bB. Hu, D. M. Gilkes, J. Chen, Cancer Res. 2007, 67, 8810; 16cC. Li, M. Liu, J. Monbo, G. Zou, W. Yuan, D. Zella, W. Y. Lu, W. Lu, J. Am. Chem. Soc. 2008, 130, 13546. 17M. Schnolzer, P. Alewood, A. Jones, D. Alewood, S. B. Kent, Int. J. Pept. Protein Res. 1992, 40, 180. 18C. N. Pace, F. Vajdos, L. Fee, G. Grimsley, T. Gray, Protein Sci. 1995, 4, 2411. Citing Literature Supporting Information Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors. Filename Description anie_201000329_sm_miscellaneous_information.pdf4.5 MB miscellaneous_information Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. Volume49, Issue21May 10, 2010Pages 3649-3652 ReferencesRelatedInformation